Specific-pathogen-free chickens vaccinated with a live FAdV-4 vaccine are fully protected against a severe challenge even in the absence of neutralizing antibodies

Avian Diseases

Volumn 54, Issue 2, 2010, Pages 905-910

  Schonewille, Esther ^a   Jaspers, Ron ^b   Paul, Guntram ^b   Hess, Michael ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

Cell mediated immune response; Hepatitishydropericardium syndrome; Live fowl adenovirus vaccine; Neutralizing antibodies; QT35 cells

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADENOVIRUS INFECTION; ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; CELL CULTURE; CHICK EMBRYO; CHICK EMBRYO LETHAL ORPHAN VIRUS; CHICKEN; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GERMFREE ANIMAL; IMMUNOLOGY; VIROLOGY;

ADENOVIRIDAE INFECTIONS; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FOWL ADENOVIRUS A; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS;

ADENOVIRIDAE; AVES; GALLUS GALLUS;

EID: 77953844532     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8999-072309-Reg.1     Document Type: Article

References (30)

1. Adair, B. M., and S. D. Fitzgerald. Group I adenovirus infections. In: Diseases of poultry, 12th ed. Y. M. Saif, A. M. Fadly, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne, eds. Wiley-Blackwell, Hoboken, NJ. pp. 252-266. 2008.
2. Afzal, M., and I. Ahmad. Efficacy of an inactivated vaccine against hydropericardium syndrome in broilers. Vet. Rec. 126:59-60. 1990.
3. Anjum, A. D. Experimental transmission of hydropericardium syndrome and protection against it in commercial broiler chickens. Avian Pathol. 19:655-660. 1990.
4. Anjum, A. D., M. A. Sabri, and Z. Iqbal. Hydropericarditis syndrome in broiler chickens in Pakistan. Vet. Rec. 124:247-248. 1989.
5. Clemmer, D. I. Age-associated changes in fecal excretion patterns of strain 93 chick embryo lethal orphan virus in chicks. Infect. Immun. 5:60-64. 1972.
6. Cook, J. K. Fowl adenoviruses: studies on aspects of the pathogenicity of six strains for 1-day-old chicks. Avian Pathol. 12:35-43. 1983.
7. Dawson, G. J., L. N. Orsi, V. J. Yates, P. W. Chang, and A. D. Pronovost. An enzyme-linked immunosorbent assay for detection of antibodies to avian adenovirus and avian adenovirus-associated virus in chickens. Avian Dis. 24:393-402. 1980.
8. Dudding, B. A., P. J. Bartelloni, R. M. Scott, F. H. Top Jr, P. K. Russell, and E. L. Buescher. Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers. Infect. Immun. 5:295-299. 1972.
9. Erny, K., J. Pallister, and M. Sheppard. Immunological and molecular comparison of fowl adenovirus serotypes 4 and 10. Arch. Virol. 140:491-501. 1995.
10. Gaydos, C. A., and J. C. Gaydos. Adenovirus vaccines in the U.S. military. Mil. Med. 160:300-304. 1995.
11. Hess, M. Detection and differentiation of avian adenoviruses: a review. Avian Pathol. 29:195-206. 2000.
12. Hess, M., R. Raue, and C. Prusas. Epidemiological studies on fowl adenoviruses isolated from cases of infectious hydropericardium. Avian Pathol. 28:433-439. 1999.
13. Horowitz, M. S. Adenoviruses. In: Fields virology, 4th ed. D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus, eds. Lippincott Williams and Wilkins, Philadelphia. pp. 2301-2326. 2001.
14. Karber, G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Path. Pharmak. 162:480-483. 1931.
15. Kaur, A., M. S. Oberoi, and A. Singh. Neutralising antibody and challenge response to live and inactivated avian adenovirus-1 in broilers. Trop. Anim. Health Prod. 29:141-146. 1997.
16. Kawamura, H., F. Shimizu, and H. Tsubahara. Avian adenovirus: its properties and serological classification. Natl. Inst. Anim. Health Q. (Tokyo) 112:183-193. 1964.
17. Kumar, R., R. Chandra, S. K. Shukla, D. K. Agrawal, and M. Kumar. Hydropericardium syndrome (HPS) in India: a preliminary study on the causative agent and control of the disease by inactivated autogenous vaccine. Trop. Anim. Health Prod. 29:158-164. 1997.
18. Lal, B., N. K. Maiti, M. S. Oberoi, and S. N. Sharma. Cell mediated immune response of chicks following fowl adenovirus type-1 infection. Comp. Immunol. Microbiol. Infect. Dis. 14:55-58. 1991.
19. Mazaheri, A., C. Prusas, M. Voß, and M. Hess. Some strains of serotype 4 fowl adenovirus cause inclusion body hepatitis and hydropericardium syndrome in chickens. Avian Pathol. 27:269-276. 1998.
20. Moscovici, C., M. G. Moscovici, H. Jimenez, M. M. Lai, M. J. Hayman, and P. K. Vogt. Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11:95-103. 1977.
21. Pallister, J. A., K. M. Erny, and K. J. Fahey. Serological relationships within group E fowl adenoviruses. Intervirology 36:54-90. 1993.
22. Reed, L., and H. Muench. A simple method estimating fifty percent endpoints. Am. J. Hyg. 27:493-497. 1938.
23. Schat, K. A., and H. G. Purchase. Cell-culture methods. In: Laboratory manual for the isolation and identification of avian pathogens, 4th ed. The American Association for Avian Pathologists, ed., Rose Printing, Tallahassee, FL. p. 223. 1998.
24. Schonewille, E., A. Singh, T. W. Gobel, W. Gerner, A. Saalmüller, and M. Hess. Fowl adenovirus (FAdV) serotype 4 causes depletion of B and T cells in lymphoid organs in specific pathogen-free chickens following experimental infection. Vet. Immunol. Immunopathol. 121:130-139. 2008.
25. Schultz, R. D. Duration of immunity for canine and feline vaccines: a review. Vet. Microbiol. 117:75-79. 2006.
26. Singh, A., G. S. Grewal, N. K. Maiti, and M. S. Oberoi. Effect of fowl adenovirus-1 (IBH isolate) on humoral and cellular immune competency of broiler chicks. Comp. Immunol. Microbiol. Infect. Dis. 29:315-321. 2006.
27. Spearman, C. The method of right and wrong cases (constant stimuli) without Gaus's formulae. Br. J. Psychol. 2:227-242. 1908.
28. Toogood, C. I., J. Crompton, and R. T. Hay. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. J. Gen. Virol. 73:1429-1435. 1992.
29. Top, F. H. Jr, R. A. Grossman, P. J. Bartelloni, H. E. Segal, B. A. Dudding, P. K. Russell, and E. L. Buescher. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J. Infect. Dis. 124:148-154. 1971.
30. van der Veen, J., M. F. Abarbanel, and K. G. Oei. 1969. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy. J. Hyg. 66:499-511. 1969.